
Deloitte ends weight-loss GLP-1 coverage and raises plan costs
Deloitte will stop covering GLP-1 drugs prescribed for weight loss from January, while raising deductibles and out-of-pocket maximums under most US health plans. The changes, detailed in an internal benefits guide seen by Business Insider, come as employers face rising healthcare costs.
























